111 (NASDAQ:YI – Get Free Report) and Clover Health Investments (NASDAQ:CLOV – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for 111 and Clover Health Investments, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| 111 | 1 | 0 | 0 | 0 | 1.00 |
| Clover Health Investments | 1 | 3 | 1 | 0 | 2.00 |
Clover Health Investments has a consensus price target of $3.82, suggesting a potential downside of 25.75%. Given Clover Health Investments’ stronger consensus rating and higher possible upside, analysts clearly believe Clover Health Investments is more favorable than 111.
Risk & Volatility
Profitability
This table compares 111 and Clover Health Investments’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| 111 | -0.76% | N/A | -3.80% |
| Clover Health Investments | -2.58% | -16.52% | -9.28% |
Valuation and Earnings
This table compares 111 and Clover Health Investments”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| 111 | $1.80 billion | 0.02 | -$9.65 million | ($1.40) | -2.64 |
| Clover Health Investments | $1.92 billion | 1.41 | -$85.55 million | ($0.12) | -42.83 |
111 has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than 111, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
21.3% of 111 shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 43.9% of 111 shares are held by company insiders. Comparatively, 23.5% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
About 111
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
